Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial
Date
2024-03-19Author
Larkin, J
Marais, R
Porta, N
de Castro, DG
Parsons, L
Messiou, C
Stamp, G
Thompson, L
Edmonds, K
Sarker, S
Banerji, J
Lorigan, P
Evans, TRJ
Corrie, P
Marshall, E
Middleton, MR
Nathan, P
Nicholson, S
Ottensmeier, C
Plummer, R
Bliss, J
Valpione, S
Turajlic, S
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Clin Trials & Stats Unit
Language
eng
Date accepted
2024-01-26
Citation
Cell Reports Medicine,
Publisher
CELL PRESS